Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Jinming Gu

Jinming Gu

Executive Director
Shanghai Hengrui Pharmaceutical
China

Biography

Dr. Jinming Gu obtained his Ph.D. degree in Molecular Biology from Vanderbilt University. He then joined Dana-Farber Cancer Institute/Harvard Medical School for a postdoctoral training in oncology. Dr. Gu started his industry career at Merrimack Pharmaceutical, Inc., where he worked on MM111, a bispecific antibody currently in Phase 2 clinical trial. He then joined Abbott Laboratories. Since joining Abbott/Abbvie, he has been leading/working on multiple mAb, ADC, and bispecific antibody programs, including ABT-806, ABT-414, and ABT-165 etc. Dr. Gu is currently the Executive Director of Biologics Discovery at Shanghai Hengrui Pharmaceutical Co., Ltd., a leading innovative pharmaceutical company in China.

Research Interest

Research Interest: Pharmaceutical R&D; Biologics Drug Discovery and Development, Cancer Immunotherapy, Biosimilar, Biobetter.